Jupiter Neurosciences Inc Share Price

NASDAQ: JUNS

Mid Cap

$1.47

-0.02

(-1.34%)

Live

as on September 19, 2025 at 12:41 am IST

$₹

Jupiter Neurosciences Inc Stock Performance

as on September 19, 2025 at 12:41 am IST

Day's Low
Day's High
$1.4
Day's Price Range
$1.56
$1.47
4.76%
Downside
6.12%
Upside
52 Week's Low
52 Week's High
$0.51
52-Week Price Range
$19.51
$1.47
65.31%
Downside
1227.21%
Upside

Jupiter Neurosciences Inc share price movements today

Previous Close: $1.49
Open: $1.50
Volume: 179.4K
Day's Low - High: $1.4 - $1.56
52 Week Low - High: $0.51 - $19.51

Jupiter Neurosciences Inc Historical Returns

1 Month Return: + 20.16 %
3 Month Return: + 20.16 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Jupiter Neurosciences Inc Stock Fundamentals & Key Indicators

Check Jupiter Neurosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$200.2M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

20718000.00%

Jupiter Neurosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jupiter Neurosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Jupiter Neurosciences Inc	NA	$200.2M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Jupiter Neurosciences Inc Stock's Interest Amongst Investors

Search interest for Jupiter Neurosciences Inc Stock has increased by 120% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 20, 2025 to September 19, 2025

Change:120% versus previous 30 day period

Jupiter Neurosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-
Operating Income	-1	0	0	0	0	-1	-1	-2
EBITDA	-1	0	0	0	0	-1	-1	-2
Interest Expense	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-1	0	0	0	0	-1	-1	-2
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-1	0	0	0	0	-1	-1	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Jupiter Neurosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	0	0	-	-
Gross Profit	1	0	0	-	-
Operating Income	-1	-3	-3	-3	-3
EBITDA	-1	-4	-4	-4	-2
Interest Expense	0	0	0	0	0
Depreciation	-	-	-	-	-
Income Before Tax	-1	-4	-4	-4	-2
Income Tax Expense	-	0	-	-	-
Net Income	-1	-4	-4	-4	-2
Net Profit Margin	-146.92%	-686.39%	-2125.15%	0.00%	0.00%

Jupiter Neurosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	0	-1	0	0	0	0	-1	-1	-2
Operating Cash Flow	0	0	0	0	0	0	-3	-1	0
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	0	0	0	0	0	7	-	-
Change in Cash	0	0	0	0	0	0	3	-1	0

Jupiter Neurosciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-1	-4	-4	-4	-2
Operating Cash Flow	0	-1	-1	0	-3
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	0	1	0	0	7
Change in Cash	0	0	0	0	3

Insights on Jupiter Neurosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, JUNS stock has moved up by 20.2%

About Jupiter Neurosciences Inc

Jupiter Neurosciences, Inc. is a clinical-stage research and development pharmaceutical company. The Company has developed a resveratrol platform product targeting the treatment of neuro-inflammation. Its product, JOTROL, has many potential indications of use for rare diseases, which primarily targets Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS). In the larger disease areas, it primarily targets Parkinson’s Disease and Mild Cognitive Impairment/early Alzheimer’s disease. The Company has designated the different indications with project numbers, JNS101 - JNS115. JOTROL is a micellar non-aqueous solution of resveratrol delivered in a soft gel capsule. Each capsule includes 100mg of resveratrol. It has a worldwide license from Aquanova AG, the patent holder of micellar technologies, to develop, manufacture, distribute and sell JOTROL.

Organisation	Jupiter Neurosciences Inc
Headquarters	1001 North US Highway 1, Jupiter, FL, United States, 33477
CEO	Mr. Christer Rosen
E-voting on shares	Click here to vote

Key Management of Jupiter Neurosciences Inc

Name	Title
Dr. Shaun P. Brothers Ph.D.	Co-Founder Member of Scientific Advisory Board & Consulting Vice President of Science Research
Mr. Christer Rosen	Co-Founder, CEO & Chairman of the Board
Ms. Alison D. Silva MA, MS	President, Chief Business Officer & Director
Dr. Marshall Hayward Ph.D.	Co-Founder, Chief Scientific Officer & Director
Mr. Alexander Rosen	Co-Founder & Chief Administrative Officer
Mr. Saleem Elmasri CPA	CFO & Secretary
Dr. Claes Wahlestedt M.D., Ph.D.	Co-Founder, Co-Chairman of Scientific Advisory Board & Consulting Chief Medical Officer

FAQs

What is Jupiter Neurosciences Inc share price today?

Jupiter Neurosciences Inc share price today is $1.47 as on September 19, 2025 at 12:41 am IST. Jupiter Neurosciences Inc share today touched a day high of $1.56 and a low of $1.4.

What is the 52 week high and 52 week low for Jupiter Neurosciences Inc share?

Jupiter Neurosciences Inc share touched a 52 week high of $19.51 on December 19, 2024 and a 52 week low of $0.51 on April 14, 2025. Jupiter Neurosciences Inc stock price today i.e. September 19, 2025 at 12:41 am IST is trending at $1.47,which is 92.47% down from its 52 week high and 188.24% up from its 52 week low.

What is Jupiter Neurosciences Inc's market capitalisation today?

Jupiter Neurosciences Inc market capitalisation is $0.00T as on September 19, 2025 at 12:41 am IST.

How to invest in Jupiter Neurosciences Inc Stock (JUNS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Jupiter Neurosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Jupiter Neurosciences Inc Shares that will get you 1.0204 shares as per Jupiter Neurosciences Inc share price of $1.47 per share as on September 19, 2025 at 12:41 am IST.

What is the minimum amount required to buy Jupiter Neurosciences Inc Stock (JUNS) from India?

Indian investors can start investing in Jupiter Neurosciences Inc (JUNS) shares with as little as ₹88.114 or $1 (as of September 19, 2025 at 12:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Jupiter Neurosciences Inc stock (as per the Rupee-Dollar exchange rate as on September 19, 2025 at 12:42 am IST). Based on Jupiter Neurosciences Inc share’s latest price of $1.47 as on September 19, 2025 at 12:41 am IST, you will get 6.8027 shares of Jupiter Neurosciences Inc. Learn more about fractional shares .